Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
belzutifan
×
90 days
×
Clear all
Filters
3
NCT04626479
2026-02-12
MK-3475-03A
Merck Sharp & Dohme LLC
Phase 1/2
Active not recruiting
400 enrolled